Alnara Pharma Raises $20 Million
Alnara Pharmaceuticals Inc., a Boston-based developer of non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases, has raised $20 million in Series A funding. Frazier Healthcare Ventures and Third Rock Ventures co-led the deal, and were joined by Bessemer Venture Partners.
30 October 2008•3 mins read
